Myocardin gene regulatory variants as surrogate markers of cardiac hypertrophy - Study in a genetically homogeneous population

Clinical Genetics

Volumn 73, Issue 1, 2008, Pages 71-78

  Kontaraki, Joanna E ^a   Parthenakis, F I ^b   Patrianakos, A P ^b   Karalis, I K ^b   Vardas, P E ^b  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Cardiac hypertrophy; Myocardin promoter; Polymorphisms

Indexed keywords

MESSENGER RNA; MYOCARDIN;

ALLELE; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ARTICLE; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HEART TUMOR; HEREDITY; HETEROZYGOTE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MARKER GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; SEQUENCE ANALYSIS; WILD TYPE;

ADULT; BIOLOGICAL MARKERS; CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; FEMALE; GREECE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TRANS-ACTIVATORS;

ANIMALIA;

EID: 37249023630     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2007.00932.x     Document Type: Article

References (34)

1. Charron P, Heron D, Gargiulo M et al. Genetic testing and genetic counselling in hypertrophic cardiomyopathy: The French experience. J Med Genet 2002: 39: 741-746.
2. Ho CY, Seidman CE. A contemporary approach to hypertrophic Ecardiomyopathy. Circulation 2006: 113: e858-e862.
3. Richard P, Charron P, Carrier L et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 2003: 107: 2227-2232.
4. Seidman J, Seidman C. The genetic basis for cardiomyopathy: From mutation identification to mechanistic paradigms. Cell 2001: 104: 557-567.
5. Arad M, Penas-Lado M, Monserrat L et al. Gene mutations in apical hypertrophic cardiomyopathy. Circulation 2005: 112: 2805-2811.
6. Heutink P, Oostra BA. Gene finding in genetically isolated populations. Hum Mol Genet 2002: 11: 2507-2515.
7. Peltonen L, Jalanko A, Varilo T. Molecular genetics of the Finnishdisease heritage. Hum Mol Genet 1999: 8: 1913-1923.
8. Du KL, Ip HS, Li J et al. Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation. Mol Cell Biol 2003: 23: 2425-2437.
9. Wang D-Z, Chang PS, Wang Z et al. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 2001: 105: 851-862.
10. Wang D-Z, Li S, Hockemeyer D et al. Potentiation of serum response factor activity by a family of myocardin-related transcription factors. Proc Natl Acad Sci U S A 2002: 99: 14855-14860.
11. Yoshida T, Sinha S, Dandre F et al. Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes. Circ Res 2003: 92: 856-864.
12. Chen J, Kitchen CM, Streb JW et al. Myocardin: A component of a molecular switch for smooth muscle differentiation. J Mol Cell Cardiol 2002: 34: 1345-1356.
13. Callis TE, Cao D, Wang D-Z. Bone morphogenetic protein signaling modulates myocardin transactivation of cardiac genes. Circ Res 2005: 97: 992-1000.
14. Pipes GCT, Creemers EE, Olson EN. The myocardin family of transcriptional coactivators: Versatile regulators of cell growth, migration, and myogenesis. Genes Dev 2006: 20: 1545-1556.
15. Zhang X, Azhar G, Chai J et al. Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factor. Am J Physiol Heart Circ Physiol 2001: 280: H1782-H1792.
16. Konhilas JP, Leinwand LA. Partnering up for cardiac hypertrophy. Circ Res 2006: 98: 985-987.
17. Nelson TJ, Balza JR, Xiao Q et al. SRF-dependent gene expression in isolated cardiomyocytes: Regulation of genes involved in cardiac hypertrophy. J Mol Cell Cardiol 2005: 39: 479-489.
18. Xing W, Zhang T-C, Cao D et al. Myocardin induces cardiomyocyte hypertrophy. Circ Res 2006: 98: 1089-1097.
19. Maron BJ, Epstein SE. Hypertrophic cardiomyopathy: A discussion of nomenclature. Am J Cardiol 1979: 43: 1242-1244.
20. Schiller N, Shah P, Crawford M et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989: 2: 358-367.
21. Sundstrom J, Evans JC, Benjamin EJ et al. Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: The Framingham Heart Study. Circulation 2004: 109: 2850-2856.
22. Devereux R, Reichek N. Echocardiographic determination of left ventricular mass in man: Anatomic validation of the method. Circulation 1977: 55: 613-618.
23. Sasieni P. From genotypes to genes: Doubling the sample size. Biometrics 1997: 53: 1253-1261.
24. Ding K, Zhou K, He F et al. LDA - a java-based linkage disequilibrium analyzer. Bioinformatics 2003: 19: 2147-2148.
25. Tregouet DA, Garelle V. A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies. Bioinformatics 2007: 23: 1038-1039.
26. Attie AD. Atherosclerosis modified. Circ Res 2001: 89: 102-104.
27. Cen B, Selvaraj A, Prywes R. Myocardin/MKL family of SRF coactivators: key regulators of immediate early and muscle specific gene expression. J Cell Biochem 2004: 93: 74-82.
28. Wang D-Z, Olson EN. Control of smooth muscle development by the myocardin family of transcriptional coactivators. Curr Opin Genet Dev 2004: 14: 558-566.
29. Wang Z, Wang D-Z, Hockemeyer D et al. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 2004: 428: 185-189.
30. Zhou J, Herring BP. Mechanisms responsible for the promoter-specific effects of myocardin. J Biol Chem 2005: 280: 10861-10869.
31. Zhou J, Hu G, Herring BP. Smooth muscle-specific genes are differentially sensitive to inhibition by Elk-1. Mol Cell Biol 2005: 25: 9874-9885.
32. Posern G, Treisman R. Actin'together: Serum response factor, its cofactors and the link to signal transduction. Trends Cell Biol 2006: 16: 588-596.
33. Gorenne I, Jin L, Yoshida T et al. LPP expression during in vitro smooth muscle differentiation and stent-induced vascular injury. Circ Res 2006: 98: 378-385.
34. Arnaiz-Villena A, Iliakis P, Gonzalez-Hevilla M et al. The origin of Cretan populations as determined by characterization of HLA alleles. Tissue Antigens 1999: 53: 213-226.